http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113018296-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4045 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4045 |
| filingDate | 2021-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-113018296-B |
| titleOfInvention | Application of melatonin in resisting porcine coronavirus |
| abstract | The application discloses application of melatonin in resisting porcine coronavirus, wherein the action mechanism of the melatonin is that the melatonin inhibits the invasion process of the virus. The melatonin related to the invention has the effect of inhibiting transmissible gastroenteritis virus (TGEV), Porcine Epidemic Diarrhea Virus (PEDV) and porcine Delta coronavirus (PDCoV) at an intracellular level. Besides, melatonin has the advantages of low price, pure nature, no toxicity and the like. The new field of the melatonin in the direction of antivirus prevention and treatment is developed, so that a new thought and direction are provided for the development of novel anti-porcine enterocoronavirus medicines. |
| priorityDate | 2021-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 118.